NCT05701527 2026-02-05
A Study of EBC-129 in Advanced Solid Tumours
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Phase 1 Recruiting
Clinical Trials
9 trialsNCT07349303 2026-01-21
NEOPRIME
Vastra Gotaland Region
Phase 2 Recruiting
NCT07136545 2025-09-10
A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)
Taipei Veterans General Hospital, Taiwan
Phase 1/2 Recruiting
NCT06670911 2025-02-24
ACCESS-I
Instituto Nacional de Cancer, Brazil
Phase 2 Recruiting
NCT06693440 2024-11-18
The Immune Assessment of PD-1 Antibody Therapy in Tumor
Henan Cancer Hospital
Recruiting
NCT06249854 2024-10-01
Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer
Korea Institute of Oriental Medicine
Phase 2 Recruiting
NCT05832827 2023-10-23
Artemis
National Cancer Center, Japan
Phase 2 Recruiting
NCT04519151 2023-06-08
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Sheba Medical Center
Phase 2 Recruiting
NCT05025813 2022-08-01
DESQUAMATE
Queensland Health
Phase 2 Recruiting